We are among the largest and fastest growing global pure-play injectable companies with our products being sold in over 60 countries across 5 continents, including the United States, Europe, Canada, Australia, India and other markets. Our key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. We are present in a vast range of therapeutic categories that include Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarial, Cardiology and more - to Hormones and Related Drugs, Fertility Supplements and Gnrh Agonists and Antagonists.
Our products are mainly used in critical care segment and hence are highly quality driven.
|Neuro / Cns||Ophthal / Otologicals|
|Others||Pain / Analgesics|
|Respiratory||Vitamins / Minerals / Nutrients|
“Gland makes its products to enhance and save the lives of patients worldwide. Drugs that form part of our portfolio are relied upon by doctors and patients in critical care therapies. Gland does not support the use of any of its products for the purpose of capital punishment. In the United States, the drugs manufactured by Gland are imported by and under the legal control of U.S. entities. They are distributed through a highly regulated, complex, vast supply chain for which Gland has no control. Gland is unaware of any distributor marketing or selling its products for lethal injection purposes or of the use of any of its products in such circumstances."